LSEG's Share Price Likely to Reflect AI Discount in Near-Term -- Market Talk
Dow Jones2026/10/08 08:410840 GMT - London Stock Exchange Group investors will likely want to see the exchange owner monetizing increased artificial-intelligence adoption by clients, UBS analysts write. They add that expectations on this front are low in the near-term given management's commentary at the first half-year earnings. "We expect LSEG will remain a 'Show Me' story with investors which means its share price will likely reflect a material AI discount in the near-term," the analysts say. UBS has a buy rating on the stock and 117.00 pound target price. Shares are up 2.2% at 84.96 pounds, but 5.1% lower over the year to date. (ian.walker@wsj.com) (END) Dow Jones Newswires October 08, 2026 04:41 ET (08:41 GMT)
0840 GMT - London Stock Exchange Group investors will likely want to see the exchange owner monetizing increased artificial-intelligence adoption by clients, UBS analysts write. They add that expectations on this front are low in the near-term given management's commentary at the first half-year earnings. "We expect LSEG will remain a 'Show Me' story with investors which means its share price will likely reflect a material AI discount in the near-term," the analysts say. UBS has a buy rating on the stock and 117.00 pound target price. Shares are up 2.2% at 84.96 pounds, but 5.1% lower over the year to date. (ian.walker@wsj.com)
(END) Dow Jones Newswires
October 08, 2026 04:41 ET (08:41 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
